Farmers & Merchants Investments Inc’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266 Hold
60
﹤0.01% 1749
2026
Q1
$262 Hold
60
﹤0.01% 1725
2025
Q4
$303 Hold
60
﹤0.01% 1694
2025
Q3
$208 Hold
60
﹤0.01% 1726
2025
Q2
$204 Hold
60
﹤0.01% 1714
2025
Q1
$241 Hold
60
﹤0.01% 1727
2024
Q4
$389 Hold
60
﹤0.01% 1708
2024
Q3
$332 Hold
60
﹤0.01% 1734
2024
Q2
$335 Hold
60
﹤0.01% 1721
2024
Q1
$403 Hold
60
﹤0.01% 1661
2023
Q4
$547 Hold
60
﹤0.01% 1610
2023
Q3
$331 Hold
60
﹤0.01% 1664
2023
Q2
$512 Buy
+60
New +$538 ﹤0.01% 1587

Other funds holding CTKB

Farmers & Merchants Investments Inc's CTKB Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Cytek Biosciences (CTKB) position steady in Q2 2026 at 60 shares worth $266. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

Farmers & Merchants Investments Inc first reported a position in CTKB in Q2 2023 and has held it in 13 quarters since. The position peaked at $547 in Q4 2023. 26 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Farmers & Merchants Investments Inc held 60 shares of Cytek Biosciences worth $266 as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Cytek Biosciences share count unchanged in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1749 holding.
  • Farmers & Merchants Investments Inc first reported a position in Cytek Biosciences in Q2 2023 and has held it in 13 quarters since.
  • Farmers & Merchants Investments Inc's Cytek Biosciences position peaked at $547 in Q4 2023.
  • 26 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.